Literature DB >> 28220211

Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?

Hans-Joachim Wittmann1, Andrea Strasser2.   

Abstract

Within the last years, for several ligands, binding to G protein-coupled receptors or other target proteins, a binding of the ligand in two different orientations is described. One appropriate experimental technique to detect two different binding orientations is the crystallization of the ligand-protein-complex, but crystallization and subsequent X-ray analysis do not belong to the routine methods. By traditional competitive radioligand equilibrium binding assays, it is not possible to detect or to distinguish between two different binding orientations, but there is a possibility to identify two different binding orientations by performing kinetic competitive radioligand-binding assays. To study the limitations of this new technique, the related differential equations were defined and solved numerically for 8 different sets of rate constants, also considering an experimental error up to ~10%. In principal, the kinetic competitive radioligand binding assay is a suitable technique to detect two different ligand binding orientations. However, the present study shows that this is only possible under distinct conditions: (1) the rate constants of dissociation for both binding orientations of the cold ligand should at least be >> 10-fold different to each other and (2) the experimental error should be as small as possible. Although there are some limitations for the experimental usability of this method, it is worthwhile to perform kinetic competitive binding assays, especially if there are hints for two binding orientations of a ligand, e.g. based on molecular modelling studies.

Keywords:  Competitive binding kinetics; Different binding orientations; Rate constant of association; Rate constant of dissociation

Mesh:

Substances:

Year:  2017        PMID: 28220211     DOI: 10.1007/s00210-017-1362-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

Review 1.  Drug-target residence time--a case for G protein-coupled receptors.

Authors:  Dong Guo; Julia M Hillger; Adriaan P IJzerman; Laura H Heitman
Journal:  Med Res Rev       Date:  2014-02-18       Impact factor: 12.944

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 3.  Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Armin Buschauer; Erich H Schneider; Roland Seifert
Journal:  Trends Pharmacol Sci       Date:  2012-12-08       Impact factor: 14.819

Review 4.  The 7 TM G-protein-coupled receptor target family.

Authors:  Edgar Jacoby; Rochdi Bouhelal; Marc Gerspacher; Klaus Seuwen
Journal:  ChemMedChem       Date:  2006-08       Impact factor: 3.466

Review 5.  Principles of early drug discovery.

Authors:  J P Hughes; S Rees; S B Kalindjian; K L Philpott
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

6.  Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Marc Kunze; Sigurd Elz; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

7.  Molecular details of the activation of the μ opioid receptor.

Authors:  Jihyun Shim; Andrew Coop; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2013-06-24       Impact factor: 2.991

8.  Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.

Authors:  Karl-Friedrich Deml; Silke Beermann; Detlef Neumann; Andrea Strasser; Roland Seifert
Journal:  Mol Pharmacol       Date:  2009-08-31       Impact factor: 4.436

9.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

10.  Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network.

Authors:  Jerome C Nwachukwu; Sathish Srinivasan; Nelson E Bruno; Alexander A Parent; Travis S Hughes; Julie A Pollock; Olsi Gjyshi; Valerie Cavett; Jason Nowak; Ruben D Garcia-Ordonez; René Houtman; Patrick R Griffin; Douglas J Kojetin; John A Katzenellenbogen; Michael D Conkright; Kendall W Nettles
Journal:  Elife       Date:  2014-04-25       Impact factor: 8.140

View more
  3 in total

Review 1.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

Review 2.  Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays.

Authors:  Reka A Otvos; Kristina B M Still; Govert W Somsen; August B Smit; Jeroen Kool
Journal:  SLAS Discov       Date:  2019-01-25       Impact factor: 3.341

3.  Utilizing the Combination of Binding Kinetics and Micro-Pharmacokinetics Link in Vitro α-Glucosidase Inhibition to in Vivo Target Occupancy.

Authors:  Guopeng Wang; Yanhua Ji; Xueyan Li; Qian Wang; Hang Gong; Baoshun Wang; Yang Liu; Yanli Pan
Journal:  Biomolecules       Date:  2019-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.